Patent · US Active

Targeting of bone marrow neovasculature

US9446124B2 · kind B2 · utility

3Cited by

3References

7Claims

0Family size

Assignee

PHILOCHEM AG · CH

Inventors

Manuela Kaspar · Brugg, CH
Christoph Schliemann · Zürich, CH
Dario Neri · Zürich, CH

Key dates

Filing date	Mar 19, 2014
Grant date	Sep 20, 2016
Priority date	—
Expiry date	Apr 14, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/64
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies which bind an antigen of the bone marrow neovasculature in leukemia patients, for use in treatment and diagnosis of leukemia, in particular the treatment and diagnosis of acute myeloid leukemia (AML).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.